News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
643,999 Results
Type
Article (54731)
Company Profile (127)
Press Release (589129)
Multimedia
Podcasts (190)
Webinars (27)
Section
Business (174268)
Career Advice (1779)
Deals (30475)
Drug Delivery (162)
Drug Development (79433)
Employer Resources (118)
FDA (16668)
Job Trends (13008)
News (310256)
Policy (34595)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2608)
Academic (2)
Accelerated approval (57)
ADA (42)
Adcomms (39)
Allergies (204)
Alliances (47026)
ALS (223)
Alzheimer's disease (1865)
Antibody-drug conjugate (ADC) (565)
Approvals (17044)
Artificial intelligence (770)
ASCO (321)
Autoimmune disease (327)
Automation (54)
Bankruptcy (290)
Best Places to Work (10058)
BIO (58)
BIOSECURE Act (22)
Biosimilars (227)
Biotechnology (97)
Bladder cancer (200)
Brain cancer (81)
Breast cancer (776)
Cancer (6159)
Cardiovascular disease (493)
Career advice (1559)
Career pathing (37)
CAR-T (331)
CDC (55)
Celiac Disease (2)
Cell therapy (927)
Cervical cancer (53)
Clinical research (69336)
Collaboration (2216)
Commercialization (1)
Company closure (5)
Compensation (875)
Complete response letters (103)
COVID-19 (2704)
CRISPR (102)
C-suite (1102)
Cystic fibrosis (143)
Data (8235)
Decentralized trials (3)
Denatured (64)
Depression (190)
Dermatology (88)
Diabetes (645)
Diagnostics (6026)
Digital health (51)
Diversity (13)
Diversity, equity & inclusion (34)
Drug discovery (412)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (288)
Earnings (75070)
Editorial (72)
Employer branding (15)
Employer resources (106)
Events (95055)
Executive appointments (999)
FDA (20669)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (34)
Funding (1713)
Gene editing (224)
Generative AI (75)
Gene therapy (729)
GLP-1 (1222)
Government (4851)
Grass and pollen (8)
Guidances (411)
Healthcare (16271)
Hematology (177)
HIV (93)
Huntington's disease (58)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (111)
Immunology and inflammation (318)
Immuno-oncology (106)
Indications (202)
Infectious disease (3046)
Inflammatory bowel disease (226)
Inflation Reduction Act (17)
Influenza (128)
Intellectual property (305)
Interviews (302)
IPO (14796)
IRA (61)
Job creations (3250)
Job search strategy (1291)
JPM (66)
Kidney cancer (22)
Labor market (85)
Layoffs (566)
Leadership (37)
Legal (8711)
Liver cancer (104)
Longevity (34)
Lung cancer (824)
Lymphoma (463)
Machine learning (62)
Management (39)
Manufacturing (1100)
Marketing (2)
MASH (211)
Medical affairs (1)
Medical device (10904)
Medtech (11036)
Mergers & acquisitions (16898)
Metabolic disorders (1703)
mRNA (223)
Multiple sclerosis (197)
NASH (20)
Neurodegenerative disease (476)
Neuropsychiatric disorders (124)
Neuroscience (3510)
Neurotech (1)
NextGen: Class of 2026 (5537)
Non-profit (4146)
Now hiring (36)
Obesity (825)
Opinion (344)
Ovarian cancer (232)
Pain (261)
Pancreatic cancer (341)
Parkinson's disease (387)
Partnered (35)
Patents (621)
Patient recruitment (703)
Peanut (71)
People (50595)
Pharmaceutical (27)
Pharmacy benefit managers (36)
Phase 1 (21223)
Phase 2 (30039)
Phase 3 (23387)
Pipeline (9346)
Policy (374)
Postmarket research (2969)
Preclinical (9037)
Press Release (64)
Prostate cancer (328)
Psychedelics (70)
Radiopharmaceuticals (327)
Rare diseases (1173)
Real estate (4772)
Recruiting (48)
Regulatory (26940)
Reports (40)
Research institute (2559)
Resumes & cover letters (249)
Rett syndrome (42)
RNA editing (21)
RSV (72)
Schizophrenia (186)
Series A (295)
Series B (194)
Service/supplier (7)
Sickle cell disease (116)
Special edition (28)
Spinal muscular atrophy (183)
Sponsored (44)
Startups (3134)
State (2)
Stomach cancer (20)
Supply chain (132)
Tariffs (93)
The Weekly (124)
Vaccines (1080)
Venture capital (122)
Weight loss (564)
Women's health (122)
Worklife (17)
Date
Today (106)
Last 7 days (405)
Last 30 days (2407)
Last 365 days (28466)
2026 (14626)
2025 (28274)
2024 (32113)
2023 (35972)
2022 (45682)
2021 (49022)
2020 (47398)
2019 (40926)
2018 (31008)
2017 (29933)
2016 (28905)
2015 (33386)
2014 (27118)
2013 (23325)
2012 (24447)
2011 (24472)
2010 (23029)
Location
Africa (854)
Alabama (94)
Alaska (6)
Arizona (260)
Arkansas (14)
Asia (40587)
Australia (6736)
California (12290)
Canada (3675)
China (1509)
Colorado (530)
Connecticut (573)
Delaware (383)
Europe (89117)
Florida (1949)
Georgia (410)
Hawaii (3)
Idaho (44)
Illinois (1018)
India (97)
Indiana (576)
Iowa (19)
Japan (574)
Kansas (122)
Kentucky (52)
Louisiana (51)
Maine (51)
Maryland (1538)
Massachusetts (8769)
Michigan (367)
Minnesota (582)
Mississippi (4)
Missouri (125)
Montana (29)
Nebraska (22)
Nevada (124)
New Hampshire (75)
New Jersey (3480)
New Mexico (25)
New York (3377)
North Carolina (1563)
North Dakota (8)
Northern California (6107)
Ohio (353)
Oklahoma (24)
Oregon (32)
Pennsylvania (2469)
Puerto Rico (33)
Rhode Island (46)
South America (1114)
South Carolina (70)
South Dakota (1)
Southern California (4980)
Tennessee (200)
Texas (2023)
United States (44007)
Utah (355)
Vermont (2)
Virginia (321)
Washington D.C. (77)
Washington State (1043)
West Virginia (4)
Wisconsin (118)
Wyoming (2)
643,999 Results for "food and drug law institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AI Detection and Repurposed Drugs Signal New Era in Food Allergy Research at Food Allergy Fund Summit
April 29, 2026
·
5 min read
Press Releases
Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1
June 14, 2026
·
6 min read
Press Releases
BioPorto initiates U.S. Adult Validation Study following U.S. Food and Drug Administration (FDA) feedback
June 9, 2026
·
5 min read
Press Releases
Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome
June 15, 2026
·
8 min read
Press Releases
Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live]
May 18, 2026
·
5 min read
Press Releases
Organon Secures US Food and Drug Administration Approval Expanding Indications for TOFIDENCE® (tocilizumab-bavi) in Cytokine Release Syndrome (CRS) and Pediatric COVID-19
June 10, 2026
·
15 min read
Press Releases
Belite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease
April 22, 2026
·
5 min read
Press Releases
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Supplemental New Drug Application for Camzyos (mavacamten) to Treat Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
June 1, 2026
·
17 min read
Press Releases
Vivos Inc. (OTCQB: RDGL) submits Early Feasibility Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) for RadioGel® Precision Radionuclide Therapy™
June 7, 2026
·
3 min read
Press Releases
BioXcel Therapeutics Announces Food & Drug Administration Acceptance of Supplemental New Drug Application for Use of IGALMI® in the At-Home Setting
April 1, 2026
·
10 min read
1 of 64,400
Next
